Lipid Dys-Homeostasis Contributes to APOE4-Associated AD Pathology

Area of Science:

• Neuroscience
• Genetics
• Biochemistry

Background:

• The APOE4 isoform is a significant genetic risk factor for Alzheimer's disease (AD).
• The precise mechanisms linking APOE4 to AD pathogenesis are not fully understood, though impaired amyloid-beta (Aβ) clearance is a leading hypothesis.
• APOE's role in lipid transport suggests lipids may mediate APOE4's detrimental effects.

Purpose of the Study:

• To investigate the impact of APOE4, compared to APOE3, on brain lipid homeostasis.
• To explore the relationship between APOE4-associated lipid changes and neurotoxic protein levels (Aβ, tau).

Main Methods:

• Analysis of lipid homeostasis pathways in the brains of mice expressing human APOE4 versus APOE3.
• Assessment of cholesterol turnover, phospholipid profiles, and fatty acid levels.
• Evaluation of Aβ, tau, and phosphorylated tau levels in primary neuronal cultures.

Main Results:

• APOE4 carriers exhibited altered cholesterol metabolism and imbalanced phospholipid ratios.
• Lower levels of polyunsaturated fatty acid-containing phosphatidylethanolamines and higher monounsaturated fatty acids were observed in APOE4 brains.
• These lipid homeostasis disruptions correlated with increased Aβ production and elevated tau/phosphorylated tau levels.

Conclusions:

• APOE4 significantly disrupts brain lipid homeostasis, affecting cholesterol and phospholipid metabolism.
• APOE4-associated lipid anomalies are linked to increased production of AD-related neurotoxic proteins.
• These findings provide new insights into APOE4's role in AD pathophysiology and suggest lipid-modulating therapies as a potential intervention strategy.